86975 Rbc serum pretx incubj drugs
Also known as: RBC-serum drug pretreatment, Inhibitor incubation
Red blood cell and serum pretreatment with drugs or inhibitors to enhance antibody identification. Diminishes unwanted reactivity.
In Plain Language
Chemical inhibitor treatment of blood test
Clinical Context
Pretreatment with inhibitors or specific drugs to eliminate nonspecific reactions and enhance identification of clinically significant antibodies.
RVU Information
CPT 86975 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 86975?
CPT 86975 (Rbc serum pretx incubj drugs) is a Pathology & Lab code. Red blood cell and serum pretreatment with drugs or inhibitors to enhance antibody identification. Diminishes unwanted reactivity.
Who uses CPT code 86975?
CPT 86975 is used by Transfusion Medicine, Pathology. Pretreatment with inhibitors or specific drugs to eliminate nonspecific reactions and enhance identification of clinically significant antibodies.
When is CPT 86975 used?
Pretreatment with inhibitors or specific drugs to eliminate nonspecific reactions and enhance identification of clinically significant antibodies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.